Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Neurologia (Barcelona, Spain)
|
November 12, 1998
[Negative cortical myoclonus]
A Gironell, J Kulisevsky, M Barbanoj
Clinical Neuropharmacology
|
October 1, 1994
Double-blind trial of flumazenil in hemiballismus
J Kulisevsky, A Avila, M L Berthier, et al.
Journal of Chromatography. A
|
March 18, 2000
Quantitation of nifedipine in human plasma by on-line solid-phase extraction and high-performance liquid chromatography
M Yriti, P Parra, E Iglesias, et al.
Neurologia (Barcelona, Spain)
|
August 1, 1997
[Psychogenic tremor: clinical, electrophysiologic and psychopathologic assessment]
A Gironell, D López-Villegas, M Barbanoj, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
June 11, 1998
Tissue factor pathway inhibitor and anti-FXa kinetic profiles of a new low-molecular-mass heparin, Bemiparin, at therapeutic subcutaneous doses
L Falkon, M Garí, M Barbanoj, et al.
European Journal of Pharmacology
|
May 24, 2000
Lack of synergism between caffeine and SKF 38393 on rotational behavior in 6-hydroxydopamine-denervated rats
M Casas, G Prat, A Rubio, et al.
Journal of Chromatography. A
|
July 27, 1999
Piroxicam quantitation in human plasma by high-performance liquid chromatography with on- and off-line solid-phase extraction
M Yritia, P Parra, J M Fernández, et al.
Clinical Neuropharmacology
|
October 1, 1995
Levodopa does not aggravate postural tremor in Parkinson's disease
J Kulisevsky, A Avila, M Barbanoj, et al.
Thrombosis and Haemostasis
|
January 1, 1997
Pharmacokinetics and tolerability of a new low molecular mass heparin (RO-11) in healthy volunteers--a dose-finding study within the therapeutical range
L Falkon, M Bayés, G Frontera, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
August 28, 2009
Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances
V Pérez, C Marin, A Rubio, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Neurologia (Barcelona, Spain)
|
November 12, 1998
[Negative cortical myoclonus]
A Gironell, J Kulisevsky, M Barbanoj
Clinical Neuropharmacology
|
October 1, 1994
Double-blind trial of flumazenil in hemiballismus
J Kulisevsky, A Avila, M L Berthier, et al.
Journal of Chromatography. A
|
March 18, 2000
Quantitation of nifedipine in human plasma by on-line solid-phase extraction and high-performance liquid chromatography
M Yriti, P Parra, E Iglesias, et al.
Neurologia (Barcelona, Spain)
|
August 1, 1997
[Psychogenic tremor: clinical, electrophysiologic and psychopathologic assessment]
A Gironell, D López-Villegas, M Barbanoj, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
June 11, 1998
Tissue factor pathway inhibitor and anti-FXa kinetic profiles of a new low-molecular-mass heparin, Bemiparin, at therapeutic subcutaneous doses
L Falkon, M Garí, M Barbanoj, et al.
European Journal of Pharmacology
|
May 24, 2000
Lack of synergism between caffeine and SKF 38393 on rotational behavior in 6-hydroxydopamine-denervated rats
M Casas, G Prat, A Rubio, et al.
Journal of Chromatography. A
|
July 27, 1999
Piroxicam quantitation in human plasma by high-performance liquid chromatography with on- and off-line solid-phase extraction
M Yritia, P Parra, J M Fernández, et al.
Clinical Neuropharmacology
|
October 1, 1995
Levodopa does not aggravate postural tremor in Parkinson's disease
J Kulisevsky, A Avila, M Barbanoj, et al.
Thrombosis and Haemostasis
|
January 1, 1997
Pharmacokinetics and tolerability of a new low molecular mass heparin (RO-11) in healthy volunteers--a dose-finding study within the therapeutical range
L Falkon, M Bayés, G Frontera, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
August 28, 2009
Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances
V Pérez, C Marin, A Rubio, et al.
Page
of 3